Close Menu

This story has been updated from a previous version to include comments made by Qiagen CEO Thierry Bernard in an earnings call.

NEW YORK – Qiagen reported on Tuesday afternoon that its third quarter revenues increased 26 percent year over year, prompting the firm to adjust its full-year financial outlook upwards.

Qiagen released its Q3 financial results a little more than a week ahead of the originally planned date of Nov. 4.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.